RxDoctor Payments Data

Erika McCarty

Nurse Practitioner · Anderson, SCNPI 1780046102

Payments from drug & device makers

$4,583in general payments, 2019–2025

Across 232 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$882
  • Merck$644
  • Boston Scientific$474
  • Novartis$418
  • Boehringer Ingelheim$278
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$246
  • plus $2K from 20 others

What the payments were for

  • Travel & lodging$792%
  • Food & beverage$4,48198%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,583 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$21,699
Medicare patients
152
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan245$183,413
JardianceEmpagliflozin210$152,246
FarxigaDapagliflozin Propanediol96$76,212
VerquvoVericiguat17$11,247
Furosemide257$1,514
Spironolactone231$1,354
Albuterol Sulfate HfaAlbuterol Sulfate30$1,095
Carvedilol125$995
Bumetanide34$681
Potassium Chloride39$565
Metoprolol Succinate50$417
Atorvastatin Calcium16$205
Hydralazine Hcl19$190
Metoprolol Tartrate14$176
Torsemide12$141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$418$183,413245 claims
Boehringer IngelheimJardiance$278$152,246210 claims
AstraZenecaFarxiga$234$76,21296 claims
MerckVerquvo$644$11,24717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →